Quest Diagnostics Incorporated operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Quest Diagnostics Incorporated with three other
pharmaceutical manufacturers in North America:
sales of $7.92 billion
of which 84%
was CSL Behring),
Regeneron Pharmaceuticals Incorporated
of which 100%
was Research & Development), and
Bausch Health Companies Inc
based in Canada
(10.89 billion Canadian Dollars [US$8.25 billion]
of which 56%
was Bausch + Lomb / International segment).
During the year ended December of 2018, sales at
Quest Diagnostics Incorporated were $7.53 billion.
decrease of 2.3%
versus 2017, when the company's sales were $7.71 billion.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Quest Diagnostics Incorporated had sales
of $7.15 billion.
Contributing to the drop in overall sales was the 3.5% decline
in All Other Operating Segments, from $339.00 million to $327.00 million.
There were also decreases in sales in
Dis Business (down 2.3% to $7.20 billion)